Aspire Biopharma Holdings Inc (ASBP)

$0.38 -0.04 (-8.62%)
Market Cap 19.01M
Revenue (ttm) 0.00
Net Income (ttm) -12.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.59
Volume 18,400,398
Avg Vol 27,289,332
Day's Range N/A - N/A
Shares Out 49.53M
Stochastic %K 68%
Beta 0.67
Analysts Strong Buy
Price Target N/A

Company Profile

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testos...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 592 7399
Address:
23150 Fashion Drive, Suite 232, Estero, United States
davis8uni
davis8uni Oct. 5 at 1:04 AM
$ASBP
0 · Reply
StockMasterHere
StockMasterHere Oct. 4 at 4:14 PM
$EZGO Thank you, bro. Will be loading the boat. Come join the party Check the website: https://www.ezgotech.com.cn/ O/S only 5,675,172 Revenue: $20.1M ( FY 2024 ) Revenue ( FY 2025 Projected ): $100M $ABP $ITP $VYNE $ASBP https://www.sec.gov/ix?doc=/Archives/edgar/data/0001806904/000121390025004698/ea0227793-20f_ezgotech.htm
0 · Reply
davis8uni
davis8uni Oct. 4 at 2:44 PM
$ASBP
0 · Reply
davis8uni
davis8uni Oct. 4 at 1:13 AM
$ASBP
0 · Reply
CristoferAtlantis
CristoferAtlantis Oct. 4 at 12:36 AM
$ASBP When reverse split?
0 · Reply
AmericanPulse
AmericanPulse Oct. 3 at 9:48 PM
$ASBP Support your stock, champions. Don't just sit and watch. Support the stock by all possible means. 💪🏼💪🏼 let's go
0 · Reply
AmericanPulse
AmericanPulse Oct. 3 at 9:38 PM
$ASBP It will explode inevitably. Watch and enjoy. 🚀😎🤌🏼
0 · Reply
verywellunknown
verywellunknown Oct. 3 at 9:14 PM
$ASBP $IXHL
0 · Reply
DDavidson777
DDavidson777 Oct. 3 at 9:01 PM
$IXHL put half my $150K profits from $ASBP this week into my $IXHL today. some big PR coming next week, most likely Monday! Load up now and let’s get rich together 📈📈📈💚 follow for more bangers
1 · Reply
JLynneB51671
JLynneB51671 Oct. 3 at 8:31 PM
$ASBP 😁🙌🚀🤑♉️
0 · Reply
Latest News on ASBP
Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025

Oct 3, 2025, 11:30 AM EDT - 1 day ago

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

Oct 2, 2025, 2:44 PM EDT - 2 days ago

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication

Oct 1, 2025, 8:30 AM EDT - 3 days ago

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product

Sep 17, 2025, 8:30 AM EDT - 17 days ago

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Sep 16, 2025, 8:30 AM EDT - 18 days ago

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Sep 3, 2025, 8:30 AM EDT - 4 weeks ago

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aug 18, 2025, 8:30 AM EDT - 6 weeks ago

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Aug 14, 2025, 8:00 AM EDT - 7 weeks ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aug 13, 2025, 9:10 AM EDT - 7 weeks ago

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement

Jul 31, 2025, 8:30 AM EDT - 2 months ago

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement

Aspire Biopharma Holdings, Inc. Announces CEO Transition

Jul 30, 2025, 7:45 PM EDT - 2 months ago

Aspire Biopharma Holdings, Inc. Announces CEO Transition

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Jul 22, 2025, 10:45 AM EDT - 2 months ago

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Jul 9, 2025, 8:30 AM EDT - 3 months ago

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Jun 24, 2025, 8:30 AM EDT - 3 months ago

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer

Jun 10, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

May 28, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

May 20, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

May 8, 2025, 8:00 AM EDT - 5 months ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Apr 29, 2025, 8:30 AM EDT - 5 months ago

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

Apr 14, 2025, 8:30 AM EDT - 6 months ago

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

Apr 11, 2025, 8:30 AM EDT - 6 months ago

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Apr 9, 2025, 8:30 AM EDT - 6 months ago

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

Mar 20, 2025, 8:30 AM EDT - 7 months ago

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

Mar 13, 2025, 8:30 AM EDT - 7 months ago

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

Mar 11, 2025, 8:00 AM EDT - 7 months ago

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

Mar 3, 2025, 7:30 AM EST - 7 months ago

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Feb 25, 2025, 7:30 AM EST - 7 months ago

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

Feb 20, 2025, 6:15 PM EST - 8 months ago

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

davis8uni
davis8uni Oct. 5 at 1:04 AM
$ASBP
0 · Reply
StockMasterHere
StockMasterHere Oct. 4 at 4:14 PM
$EZGO Thank you, bro. Will be loading the boat. Come join the party Check the website: https://www.ezgotech.com.cn/ O/S only 5,675,172 Revenue: $20.1M ( FY 2024 ) Revenue ( FY 2025 Projected ): $100M $ABP $ITP $VYNE $ASBP https://www.sec.gov/ix?doc=/Archives/edgar/data/0001806904/000121390025004698/ea0227793-20f_ezgotech.htm
0 · Reply
davis8uni
davis8uni Oct. 4 at 2:44 PM
$ASBP
0 · Reply
davis8uni
davis8uni Oct. 4 at 1:13 AM
$ASBP
0 · Reply
CristoferAtlantis
CristoferAtlantis Oct. 4 at 12:36 AM
$ASBP When reverse split?
0 · Reply
AmericanPulse
AmericanPulse Oct. 3 at 9:48 PM
$ASBP Support your stock, champions. Don't just sit and watch. Support the stock by all possible means. 💪🏼💪🏼 let's go
0 · Reply
AmericanPulse
AmericanPulse Oct. 3 at 9:38 PM
$ASBP It will explode inevitably. Watch and enjoy. 🚀😎🤌🏼
0 · Reply
verywellunknown
verywellunknown Oct. 3 at 9:14 PM
$ASBP $IXHL
0 · Reply
DDavidson777
DDavidson777 Oct. 3 at 9:01 PM
$IXHL put half my $150K profits from $ASBP this week into my $IXHL today. some big PR coming next week, most likely Monday! Load up now and let’s get rich together 📈📈📈💚 follow for more bangers
1 · Reply
JLynneB51671
JLynneB51671 Oct. 3 at 8:31 PM
$ASBP 😁🙌🚀🤑♉️
0 · Reply
METS1
METS1 Oct. 3 at 7:32 PM
$ASBP You see that the CEO of ASBP will be presenting and participating 1x1 meeting at the up coming NOBLE CAPITAL MARKET 2025 emerging virtual equity conference on the OCTOBER 8-9 2025
0 · Reply
METS1
METS1 Oct. 3 at 7:24 PM
$ASBP To me you have dumb people selling shares this low and helping the short sellers by doing this. My opinion
0 · Reply
davis8uni
davis8uni Oct. 3 at 6:08 PM
$ASBP
0 · Reply
Hieuthao
Hieuthao Oct. 3 at 5:21 PM
$ICCM let market digest this like it did with Aspire $ASBP and it will go up like 100% the next day. $ASBP doesnt even have analyst coverage and not even cancer related. Market loves anything cancer related
0 · Reply
super35362
super35362 Oct. 3 at 4:58 PM
$ASBP READY
0 · Reply
sn0wball
sn0wball Oct. 3 at 4:34 PM
$ASBP yea whatever, results are all over the place and not enough volume. fix your stop losses.
0 · Reply
Jmilwhiz24
Jmilwhiz24 Oct. 3 at 4:28 PM
$ASBP .40-.45 is a struggle for this one ☝️ but patience. I was also in at .33 lol
0 · Reply
sn0wball
sn0wball Oct. 3 at 4:17 PM
$ASBP
0 · Reply
EC100
EC100 Oct. 3 at 4:12 PM
$ASBP going green today
0 · Reply
TradingBeasts
TradingBeasts Oct. 3 at 4:08 PM
Huge run on ASTC today! I made a nice 8.6k$ profit :)) My best trade this month! If you like getting in these low cap bottoms before they run big, Make sure to FOLLLOW @MomentumZeus guy below! Adding more to my $ARBK $SYTA $NUTR $LKNCY $ASBP positions
0 · Reply
sn0wball
sn0wball Oct. 3 at 4:07 PM
$ASBP according to AI this is eminent short squeeze. not solid info. do your DD.
0 · Reply
sn0wball
sn0wball Oct. 3 at 4:06 PM
$ASBP this could go boom :)
0 · Reply